ECSP20016817A - Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda - Google Patents

Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Info

Publication number
ECSP20016817A
ECSP20016817A ECSENADI202016817A ECDI202016817A ECSP20016817A EC SP20016817 A ECSP20016817 A EC SP20016817A EC SENADI202016817 A ECSENADI202016817 A EC SENADI202016817A EC DI202016817 A ECDI202016817 A EC DI202016817A EC SP20016817 A ECSP20016817 A EC SP20016817A
Authority
EC
Ecuador
Prior art keywords
systems
methods
control
necrosis disease
hepatopancreatic necrosis
Prior art date
Application number
ECSENADI202016817A
Other languages
English (en)
Inventor
Elena Sineva
Sayre Richard
Tatiana Vinogradova-Shah
Original Assignee
Pebble Labs Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/025766 external-priority patent/WO2018184029A1/en
Priority claimed from PCT/US2018/033976 external-priority patent/WO2018217819A1/en
Application filed by Pebble Labs Usa Inc filed Critical Pebble Labs Usa Inc
Publication of ECSP20016817A publication Critical patent/ECSP20016817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Dentistry (AREA)
  • Virology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Insects & Arthropods (AREA)
  • Oncology (AREA)

Abstract

En general, la tecnología de la invención se refiere a novedosas estrategias para el control de enfermedades en sistemas animales. Específicamente, la tecnología de la invención se refiere a métodos, sistemas y composiciones novedosas para el biocontrol de patógenos en sistemas acuáticos. Específicamente, la invención puede comprender técnicas, sistemas y métodos novedosos para el biocontrol de patógenos transmisores de enfermedades que afectan a los camarones en los sistemas acuícolas.
ECSENADI202016817A 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda ECSP20016817A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762541824P 2017-08-07 2017-08-07
PCT/US2018/025766 WO2018184029A1 (en) 2017-03-31 2018-04-02 Novel system for the biocontrol of pathogens in aquaculture and other animal systems
PCT/US2018/033976 WO2018217819A1 (en) 2017-05-22 2018-05-22 Transbiotic regulation of bacterial gene expression

Publications (1)

Publication Number Publication Date
ECSP20016817A true ECSP20016817A (es) 2020-04-22

Family

ID=65271567

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202016817A ECSP20016817A (es) 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Country Status (9)

Country Link
US (1) US11944676B2 (es)
EP (1) EP3664616A4 (es)
CN (1) CN111433349A (es)
BR (1) BR112020002689A2 (es)
CL (1) CL2020000329A1 (es)
EC (1) ECSP20016817A (es)
MX (1) MX2020001574A (es)
SG (1) SG11202001143YA (es)
WO (1) WO2019032629A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001574A (es) 2017-08-07 2020-09-03 Pebble Labs Usa Inc Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.
CN110317792B (zh) * 2019-06-03 2021-05-25 台州学院 副溶血弧菌噬菌体vp-hyp2及其应用
US20220313783A1 (en) * 2019-09-05 2022-10-06 Pebble Labs Inc. Systems, Methods and Compositions for the Inhibition of Bacterial Toxins to Treat Early Mortality Syndrome in Aquatic Animals
US20230233621A1 (en) * 2020-06-12 2023-07-27 Pebble Labs Inc. Novel probiotic bacteria and methods to control pathogens in aquatic animals
CN112753629B (zh) * 2020-12-30 2022-08-30 亚太海洋生物科技(厦门)有限公司 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
US7183099B2 (en) * 2001-10-26 2007-02-27 Princeton University Inhibitors of autoinducer transporters
US20050227933A1 (en) 2001-11-29 2005-10-13 Benkovic Stephen J Treatment of bacterial induced diseases using DNA methyl transferase inhibitors
US8633028B2 (en) * 2003-07-02 2014-01-21 Musc Foundation For Research Development dsRNA induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
US7247437B2 (en) 2003-08-21 2007-07-24 Trustees Of Tufts College Vibrionaceae replication factors and methods of use thereof
US20050158326A1 (en) 2003-12-24 2005-07-21 Chin-Yu Chen Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof
WO2005079236A2 (en) * 2004-02-06 2005-09-01 Advanced Bionutrition Corporation Rna-mediated interference to control disease in terrestrial and aquaculture animals
US20080107652A1 (en) 2006-08-25 2008-05-08 Science & Technology Corporation @ University Of New Mexico Stc.Unm Methods and compositions for control of disease in aquaculture
JP6084771B2 (ja) 2008-09-17 2017-02-22 バイエル クロップサイエンス エルピーＢａｙｅｒ Ｃｒｏｐｓｃｉｅｎｃｅ Ｌｐ 動物の健康を向上するためにバチルス・ズブチリス株を使用する方法
US20120107355A1 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
KR101242821B1 (ko) * 2011-01-31 2013-03-12 씨제이제일제당 (주) 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스
KR101049672B1 (ko) 2011-02-01 2011-07-14 박명진 초음파 유도하 중재적 시술용 바늘구조
GB201107768D0 (en) 2011-05-10 2011-06-22 Univ Manchester Riboswitches
US9932598B2 (en) 2012-08-02 2018-04-03 The Regents Of The University Of California Metabolic engineering of microbial organisms
ES2691803T3 (es) 2013-03-15 2018-11-28 Monsanto Technology Llc Composiciones y procedimientos para la producción y administración de ARN
US10767156B2 (en) * 2013-10-24 2020-09-08 Yeda Research And Development Co., Ltd. Polynucleotides encoding BREX system polypeptides and methods of using same
US20150125545A1 (en) * 2013-11-04 2015-05-07 Aardvark Ip Holding, Llc Aquaculture water treatment systems and methods
KR20190095252A (ko) 2016-09-16 2019-08-14 페블 랩스 질병-전염성 모기의 생물학적 방제를 위한 파라트랜스제닉 시스템
CN110997911A (zh) 2017-03-31 2020-04-10 卵石实验室公司 水产养殖和其他动物系统中病原菌生物控制的新系统
MX2019013997A (es) 2017-05-22 2020-07-29 Pebble Labs Usa Inc Regulacion transbiotica de expresion genica bacteriana.
MX2020001574A (es) 2017-08-07 2020-09-03 Pebble Labs Usa Inc Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.

Also Published As

Publication number Publication date
MX2020001574A (es) 2020-09-03
US11944676B2 (en) 2024-04-02
CN111433349A (zh) 2020-07-17
EP3664616A1 (en) 2020-06-17
US20200178566A1 (en) 2020-06-11
WO2019032629A1 (en) 2019-02-14
BR112020002689A2 (pt) 2020-08-25
EP3664616A4 (en) 2021-08-11
CL2020000329A1 (es) 2020-08-14
SG11202001143YA (en) 2020-03-30

Similar Documents

Publication Publication Date Title
ECSP20016817A (es) Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
MX382230B (es) Composiciones y metodos para modular la expresion de similar a la angiopoyetina tipo 3.
CL2016003191A1 (es) Polipéptidos receptores formulados y métodos relacionados
CL2018000052A1 (es) Heterociclos nitrogenados como pesticidas.
BR112017005388A2 (pt) método para criar animais.
MX2020011100A (es) Compuestos, composiciones farmaceuticas y metodos de uso de agonistas de ppar.
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
MX391988B (es) Sistema novedoso para el biocontrol de patógenos en sistemas de acuicultura y otros sistemas animales.
CR11810A (es) Compuestos de 1,2-benzotiazolo utiles para combatir plagas animales
CL2018002645A1 (es) Sulfonamidas sustituidas para controlar plagas animales
MX384427B (es) Composiciones de proteína concentrada y métodos para su elaboración y uso.
AR111837A1 (es) Plantas transgénicas inmunomoduladoras y métodos relacionados
MX2018012538A (es) Agonistas del receptor activado por proliferador de peroxisoma (ppar), compuestos, composiciones farmaceuticas y metodos para usar los mismos.
EA201891342A1 (ru) Изоиндольные соединения
CL2020003168A1 (es) Métodos de uso de cd24 para prevenir y tratar la enfermedad de injerto contra huésped y la mucositis
CL2018003037A1 (es) 2-alquilimidazolilcarboxamidas sustituidas como plaguicidas.
CL2021001689A1 (es) Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo.
CL2017002931A1 (es) Método para incrementar la utilización de proteína de soja por peces salmónidos.
BR112021020349A2 (pt) Peixe estéril
UY37979A (es) Sistema de cosecha subacuática mejorado
BR112017017974A2 (pt) método para a fabricação de uma ração, método não terapêutico, ração em gel não estruturada e composição de base de pectina
ECSP20019404A (es) Agentes microbianos para alimentación directa para mejorar el estado general y salud de los peces
CL2018001084A1 (es) Dieta artificial para la crianza de rhyzobius lophanthae, familia coccinellidae, enemigo natural de escamas (coccoidea), método de preparación de la dieta.
EA202090997A1 (ru) Усовершенствованная подводная промысловая система